(Q51795493)
Statements
Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition. (English)
1 reference
Takuma Mihara
1 reference
Kayoko Mihara
1 reference
Junko Yarimizu
1 reference
Yasuyuki Mitani
1 reference
Ritsuko Matsuda
1 reference
Hiroko Yamamoto
1 reference
Satoshi Aoki
1 reference
Atsushi Akahane
1 reference
Akinori Iwashita
1 reference
Nobuya Matsuoka
1 reference
7 August 2007
1 reference
323
1 reference
2
1 reference
708-719
1 reference